IBDEI2FF ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41161,1,3,0)
 ;;=3^Overactive Bladder
 ;;^UTILITY(U,$J,358.3,41161,1,4,0)
 ;;=4^N32.81
 ;;^UTILITY(U,$J,358.3,41161,2)
 ;;=^5015652
 ;;^UTILITY(U,$J,358.3,41162,0)
 ;;=Q61.2^^159^2000^79
 ;;^UTILITY(U,$J,358.3,41162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41162,1,3,0)
 ;;=3^Polycystic Kidney,Adult Type
 ;;^UTILITY(U,$J,358.3,41162,1,4,0)
 ;;=4^Q61.2
 ;;^UTILITY(U,$J,358.3,41162,2)
 ;;=^5018796
 ;;^UTILITY(U,$J,358.3,41163,0)
 ;;=N41.1^^159^2000^83
 ;;^UTILITY(U,$J,358.3,41163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41163,1,3,0)
 ;;=3^Prostatitis,Chronic
 ;;^UTILITY(U,$J,358.3,41163,1,4,0)
 ;;=4^N41.1
 ;;^UTILITY(U,$J,358.3,41163,2)
 ;;=^186931
 ;;^UTILITY(U,$J,358.3,41164,0)
 ;;=N11.9^^159^2000^91
 ;;^UTILITY(U,$J,358.3,41164,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41164,1,3,0)
 ;;=3^Pyelonephritis,Chronic,Unspec
 ;;^UTILITY(U,$J,358.3,41164,1,4,0)
 ;;=4^N11.9
 ;;^UTILITY(U,$J,358.3,41164,2)
 ;;=^5015574
 ;;^UTILITY(U,$J,358.3,41165,0)
 ;;=N20.9^^159^2000^102
 ;;^UTILITY(U,$J,358.3,41165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41165,1,3,0)
 ;;=3^Urinary Calculus,Unspec
 ;;^UTILITY(U,$J,358.3,41165,1,4,0)
 ;;=4^N20.9
 ;;^UTILITY(U,$J,358.3,41165,2)
 ;;=^5015610
 ;;^UTILITY(U,$J,358.3,41166,0)
 ;;=R51.^^159^2001^2
 ;;^UTILITY(U,$J,358.3,41166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41166,1,3,0)
 ;;=3^Headache
 ;;^UTILITY(U,$J,358.3,41166,1,4,0)
 ;;=4^R51.
 ;;^UTILITY(U,$J,358.3,41166,2)
 ;;=^5019513
 ;;^UTILITY(U,$J,358.3,41167,0)
 ;;=G44.1^^159^2001^9
 ;;^UTILITY(U,$J,358.3,41167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41167,1,3,0)
 ;;=3^Vascular Headache NEC
 ;;^UTILITY(U,$J,358.3,41167,1,4,0)
 ;;=4^G44.1
 ;;^UTILITY(U,$J,358.3,41167,2)
 ;;=^5003934
 ;;^UTILITY(U,$J,358.3,41168,0)
 ;;=G43.909^^159^2001^5
 ;;^UTILITY(U,$J,358.3,41168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41168,1,3,0)
 ;;=3^Migraine,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,41168,1,4,0)
 ;;=4^G43.909
 ;;^UTILITY(U,$J,358.3,41168,2)
 ;;=^5003909
 ;;^UTILITY(U,$J,358.3,41169,0)
 ;;=G44.009^^159^2001^1
 ;;^UTILITY(U,$J,358.3,41169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41169,1,3,0)
 ;;=3^Cluster Headache,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,41169,1,4,0)
 ;;=4^G44.009
 ;;^UTILITY(U,$J,358.3,41169,2)
 ;;=^5003921
 ;;^UTILITY(U,$J,358.3,41170,0)
 ;;=G44.40^^159^2001^4
 ;;^UTILITY(U,$J,358.3,41170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41170,1,3,0)
 ;;=3^Medication Overuse Headache,Not Intractable
 ;;^UTILITY(U,$J,358.3,41170,1,4,0)
 ;;=4^G44.40
 ;;^UTILITY(U,$J,358.3,41170,2)
 ;;=^5003947
 ;;^UTILITY(U,$J,358.3,41171,0)
 ;;=G44.89^^159^2001^3
 ;;^UTILITY(U,$J,358.3,41171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41171,1,3,0)
 ;;=3^Headache Syndrome NEC
 ;;^UTILITY(U,$J,358.3,41171,1,4,0)
 ;;=4^G44.89
 ;;^UTILITY(U,$J,358.3,41171,2)
 ;;=^5003954
 ;;^UTILITY(U,$J,358.3,41172,0)
 ;;=G44.84^^159^2001^7
 ;;^UTILITY(U,$J,358.3,41172,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41172,1,3,0)
 ;;=3^Primary Exertional Headache
 ;;^UTILITY(U,$J,358.3,41172,1,4,0)
 ;;=4^G44.84
 ;;^UTILITY(U,$J,358.3,41172,2)
 ;;=^336563
 ;;^UTILITY(U,$J,358.3,41173,0)
 ;;=G44.301^^159^2001^6
 ;;^UTILITY(U,$J,358.3,41173,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41173,1,3,0)
 ;;=3^Post-Traumatic Headache,Unspec,Intractable
 ;;^UTILITY(U,$J,358.3,41173,1,4,0)
 ;;=4^G44.301
 ;;^UTILITY(U,$J,358.3,41173,2)
 ;;=^5003941
 ;;^UTILITY(U,$J,358.3,41174,0)
 ;;=G44.209^^159^2001^8
 ;;^UTILITY(U,$J,358.3,41174,1,0)
 ;;=^358.31IA^4^2
